Logo-ipp

Immunopathol Persa. 2021;7(2): e35. doi: 10.34172/ipp.2021.35

Original

The prevalence of COVID-19 in patients with rheumatoid arthritis, multiple sclerosis, or systemic lupus erythematosus receiving biologic disease-modifying antirheumatic drugs

Arman Ahmadzadeh 1 ORCID, Faraneh Farsad 1 ORCID, Mohammad Mehdi Emam 1 ORCID, Alireza Rajaei 1 ORCID, Samaneh Hatami 1 * ORCID, Latif Gachkar 2 ORCID

Cited by CrossRef: